Lincoln Pharmaceuticals informs about disclosure of related party transactions

24 Nov 2022 Evaluate

In compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lincoln Pharmaceuticals has informed that it enclosed disclosure of related party transactions in the specified format for the half year ended September 30, 2022. The same available on the website of the Company at www.lincolnpharma.com.

The above information is a part of company’s filings submitted to BSE.

Lincoln Pharma Share Price

561.65 -1.85 (-0.33%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.